NYSEMKT: NNVC
Nanoviricides Inc Stock Ownership - Who owns Nanoviricides?

Insider buying vs selling

Have Nanoviricides Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NNVC insiders and whales buy or sell their stock.

NNVC Shareholders

What type of owners hold Nanoviricides Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Theracour Pharma Inc207.32%33,321,000$46.65MInsider
Milton Boniuk92.26%14,827,438$20.76MInsider
Anil Diwan12.72%2,044,918$2.86MInsider
Eugene Seymour7.77%1,248,814$1.75MInsider
Vanguard Group Inc3.18%510,416$714.58kInstitution
Stephenson Fournier PLLC3.06%491,721$688.41kInsider
Meeta Vyas2.74%439,570$615.40kInsider
Compagnie Lombard Odier Scma1.24%200,000$280.00kInstitution
Blackrock Inc0.99%158,752$222.25kInstitution
Geode Capital Management LLC0.96%154,590$216.43kInstitution

1 of 3

NNVC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NNVC2.76%97.24%
BOLD75.81%23.82%
CALC13.56%86.44%Net BuyingNet Buying
ALXO65.13%27.88%Net Buying
CMMB0.99%4.49%

Nanoviricides Stock Ownership FAQ

Who owns Nanoviricides?

Nanoviricides (NYSEMKT: NNVC) is owned by 9.26% institutional shareholders, 325.87% Nanoviricides insiders, and 0.00% retail investors. Theracour Pharma Inc is the largest individual Nanoviricides shareholder, owning 33.32M shares representing 207.32% of the company. Theracour Pharma Inc's Nanoviricides shares are currently valued at $46.65M.

If you're new to stock investing, here's how to buy Nanoviricides stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.